ATE481495T1 - Adenovirusvektor - Google Patents

Adenovirusvektor

Info

Publication number
ATE481495T1
ATE481495T1 AT03730847T AT03730847T ATE481495T1 AT E481495 T1 ATE481495 T1 AT E481495T1 AT 03730847 T AT03730847 T AT 03730847T AT 03730847 T AT03730847 T AT 03730847T AT E481495 T1 ATE481495 T1 AT E481495T1
Authority
AT
Austria
Prior art keywords
adenovirus vector
cells
stem cells
cell lines
specific cell
Prior art date
Application number
AT03730847T
Other languages
English (en)
Inventor
Hiroyuki Mizuguchi
Takao Hayakawa
Fuminori Sakurai
Original Assignee
Fuso Pharmaceutical Ind
Hiroyuki Mizuguchi
Takao Hayakawa
Fuminori Sakurai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29727559&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE481495(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fuso Pharmaceutical Ind, Hiroyuki Mizuguchi, Takao Hayakawa, Fuminori Sakurai filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE481495T1 publication Critical patent/ATE481495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03730847T 2002-06-05 2003-06-05 Adenovirusvektor ATE481495T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002164015A JP4237449B2 (ja) 2002-06-05 2002-06-05 アデノウィルスベクター
PCT/JP2003/007146 WO2003104469A1 (ja) 2002-06-05 2003-06-05 アデノウイルスベクター

Publications (1)

Publication Number Publication Date
ATE481495T1 true ATE481495T1 (de) 2010-10-15

Family

ID=29727559

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03730847T ATE481495T1 (de) 2002-06-05 2003-06-05 Adenovirusvektor

Country Status (8)

Country Link
US (1) US9540658B2 (de)
EP (1) EP1533381B1 (de)
JP (1) JP4237449B2 (de)
AT (1) ATE481495T1 (de)
AU (1) AU2003242160B2 (de)
CA (1) CA2488058C (de)
DE (1) DE60334222D1 (de)
WO (1) WO2003104469A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050036989A1 (en) * 2003-07-18 2005-02-17 Onyx Pharmaceuticals, Inc. Subgroup B adenoviral vectors for treating disease
DK2747551T3 (da) 2011-08-26 2020-05-18 Yecuris Corp Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf
JPWO2020166727A1 (ja) * 2019-02-12 2021-12-16 国立大学法人大阪大学 ヒト３５型アデノウイルスを基盤とした腫瘍溶解性ウイルス

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880102A (en) * 1995-01-17 1999-03-09 Duke University Adenoviral vector system
US5849561A (en) 1997-05-22 1998-12-15 Cornell Research Foundation, Inc. Method for the production of non-group C adenoviral vectors
AU777041B2 (en) * 1999-05-17 2004-09-30 Crucell Holland B.V. Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
CA2373547A1 (en) * 1999-05-27 2000-12-07 Genzyme Corporation Methods for induction of tolerance to adenoviral vectors and transgene products
US20010033833A1 (en) * 1999-12-08 2001-10-25 Schraa Edwin Oscar Method of administering adenovirus
JP4744771B2 (ja) * 2000-05-26 2011-08-10 大日本住友製薬株式会社 副作用を軽減した新規な組換えアデノウイルスベクター
EP1348030B1 (de) * 2001-01-04 2009-11-25 Wadell, Göran Virusvektor zur gentherapie
EP1539937A4 (de) * 2002-08-22 2006-07-26 Merck & Co Inc Verfahren zur vermehrung von adenovirus und damit produziertes virus

Also Published As

Publication number Publication date
US20050176129A1 (en) 2005-08-11
EP1533381A1 (de) 2005-05-25
JP2004008047A (ja) 2004-01-15
US9540658B2 (en) 2017-01-10
CA2488058A1 (en) 2003-12-18
EP1533381A4 (de) 2005-11-16
DE60334222D1 (en) 2010-10-28
AU2003242160B2 (en) 2007-08-02
WO2003104469A1 (ja) 2003-12-18
EP1533381B1 (de) 2010-09-15
JP4237449B2 (ja) 2009-03-11
CA2488058C (en) 2011-11-22
AU2003242160A1 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
HUP0003331A2 (hu) Eljárás a C-szerocsoportba nem besorolható adenovirális vektorok előállítására
BR0012099A (pt) Transferência citoplásmica para de-diferenciar células recipientes
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
NO990025D0 (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
HUP0301318A2 (hu) Replikáció-defektív rekombináns adenovírus mutáns fő késői promóterrel
MX9606476A (es) Inhibicion citoplasmica de expresion de genes.
ATE494381T1 (de) Verbesserte expressionselemente
WO2001051006A3 (en) Cardiac-cell specific enhancer elements and uses thereof
ATE473283T1 (de) Dna-expressionsvektoren
MA28779B1 (fr) Variants d'aprotinine ameliores
BRPI0303570B8 (pt) "construção de hgf, microrganismo transgênico, vetor e composição farmacêutico"
NL300046I2 (nl) Eiwit met uraat oxidase activiteit, recombinant gen dat hiervoor codeert, expressievector, micro-organismen en getransformeerde cellen.
HUP0102329A2 (hu) A humán BMP-7-promóter és alkalmazása csonttal kapcsolatos anyagok azonosítási eljárásában
HK1043812A1 (en) Mammalian expression vectors containing exogenous 5'-untranslated region as a transcription requlatory element
ATE481495T1 (de) Adenovirusvektor
WO2001030992A3 (en) α1-3 GALACTOSYLTRANSFERASE GENE AND PROMOTER
DE69940022D1 (de) Promotoren für wachstums-differenzierungsfaktoren und deren verwendung
UA126792C2 (uk) Регуляторний елемент рослин і його застосування
ATE420199T1 (de) Wirtszellen, die rekombinantes humanes erythropoietin exprimieren
ATE354643T1 (de) Immortalisierte geflügelzellinien
ATE338826T1 (de) Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression
ATE317020T1 (de) Neues regulationssystem zur kontrolle der expression eines transgens
HUP9904201A1 (hu) Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény
RU2009104533A (ru) Способы обнаружения болезни альцгеймера
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties